$CPIX News

Cumberland And Vanderbilt Announce Phase 2a Clinical Trial Of Ifetroban Met Primary Endpoint Demonstrating Safety And Tolerability Of Ifetroban In Patients With High-Risk Solid Tumors

Cumberland Posts Loss in Q1 Amid $100M Apotex Deal Plan

Cumberland Pharmaceuticals Inc. Q1 2026 Earnings Call Summary

Cumberland Pharmaceuticals Inc. (CPIX) Q1 2026 Earnings Call Transcript

Cumberland Pharmaceuticals Q1 Earnings Call Highlights

CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE

Full Transcript: Cumberland Q1 2026 Earnings Call

Cumberland Q1 Adj. EPS $(0.13) Down From $0.16 YoY, Sales $9.131M Down From $11.713M YoY

Cumberland Pharmaceuticals (CPIX) Integrates Commercial Business with Apotex

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE

Cumberland to sell drug portfolio to Apotex for $100m

Cumberland Pharmaceuticals jumps on $100M Apotex transaction

Apotex Announces Strategic Transaction with Cumberland Pharmaceuticals to Integrate their U.S. Branded Businesses

Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex

Cumberland Pharmaceuticals Shares Halted On Circuit Breaker To The Downside, Stock Now Up 69.18%

Cumberland Pharmaceuticals Shares Halted On Circuit Breaker To The Downside, Stock Now Up 69.18%

Cumberland Pharmaceuticals shares are trading higher after the company announced that Apotex will acquire its line of branded pharmaceuticals for $100 million.

Cumberland Pharmaceuticals Announces That Apotex Will Acquire The Company's Line Of Branded Pharmaceuticals For $100M In Cash

RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026

CUMBERLAND PHARMACEUTICALS ANNOUNCES EXPANDED INDICATION FOR CALDOLOR® (IBUPROFEN) INJECTION AND LAUNCH OF NEW BRAND WEBSITE